Company Filing History:
Years Active: 2008-2022
Title: Innovations in Cancer Treatment by Inventor Ping Li
Introduction
Ping Li is a notable inventor based in Houston, TX, who has made significant contributions to the field of cancer treatment. With a total of 3 patents, his work focuses on innovative methods for targeting specific kinases and understanding the role of certain proteins in cancer prognosis.
Latest Patents
One of his latest patents is titled "Targeting kinases for the treatment of cancer metastasis." This patent provides methods for treating brain metastasis by administering a kinase inhibitor that targets a metastasis-promoting kinase identified through an in vivo kinase screen. Another important patent is "14-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types." This patent discloses methods for determining prognosis in subjects with hyperproliferative diseases, including the expression and function of 14-3-3 zeta. It also outlines the process of creating a pharmaceutical agent that modulates apoptosis, which can be used in treating various cancers, such as breast cancer.
Career Highlights
Ping Li is affiliated with the University of Texas System, where he continues to advance research in cancer therapies. His work has been instrumental in developing new treatment strategies that could potentially improve patient outcomes.
Collaborations
He collaborates with esteemed colleagues, including Dihua Yu and Jun Yao, to further enhance the impact of his research in the medical community.
Conclusion
Ping Li's innovative patents and research efforts are paving the way for new cancer treatment methodologies. His contributions are vital in the ongoing battle against cancer, showcasing the importance of targeted therapies in improving patient care.